BioFusionNet: Deep Learning-Based Survival Risk Stratification in ER+ Breast Cancer Through Multifeature and Multimodal Data Fusion
2402.10717
0
0
🤿
Abstract
Breast cancer is a significant health concern affecting millions of women worldwide. Accurate survival risk stratification plays a crucial role in guiding personalised treatment decisions and improving patient outcomes. Here we present BioFusionNet, a deep learning framework that fuses image-derived features with genetic and clinical data to obtain a holistic profile and achieve survival risk stratification of ER+ breast cancer patients. We employ multiple self-supervised feature extractors (DINO and MoCoV3) pretrained on histopathological patches to capture detailed image features. These features are then fused by a variational autoencoder and fed to a self-attention network generating patient-level features. A co-dual-cross-attention mechanism combines the histopathological features with genetic data, enabling the model to capture the interplay between them. Additionally, clinical data is incorporated using a feed-forward network, further enhancing predictive performance and achieving comprehensive multimodal feature integration. Furthermore, we introduce a weighted Cox loss function, specifically designed to handle imbalanced survival data, which is a common challenge. Our model achieves a mean concordance index of 0.77 and a time-dependent area under the curve of 0.84, outperforming state-of-the-art methods. It predicts risk (high versus low) with prognostic significance for overall survival in univariate analysis (HR=2.99, 95% CI: 1.88--4.78, p<0.005), and maintains independent significance in multivariate analysis incorporating standard clinicopathological variables (HR=2.91, 95% CI: 1.80--4.68, p<0.005).
Create account to get full access
Overview
- Breast cancer is a major health concern affecting many women worldwide.
- Accurately predicting survival risk is crucial for personalized treatment and patient outcomes.
- The researchers developed a deep learning framework called BioFusionNet to integrate image, genetic, and clinical data for survival risk stratification in estrogen receptor-positive (ER+) breast cancer patients.
Plain English Explanation
The researchers wanted to create a better way to predict how long patients with a certain type of breast cancer (ER+ breast cancer) might survive. Accurately predicting survival risk is important because it helps doctors make the best treatment decisions for each patient.
BioFusionNet is a deep learning model, which means it uses artificial intelligence to analyze data and make predictions. This model takes three different types of data about the patients and combines them to get a more complete picture:
-
Image data: The model looks at images of the cancer tissue under a microscope to find important visual features.
-
Genetic data: The model also looks at the patients' genetic information, which can provide clues about how the cancer might behave.
-
Clinical data: Things like the patient's age, tumor size, and other medical factors are also incorporated.
By combining all these different types of data, the model can make more accurate predictions about how long each patient might survive. This is important because it helps doctors tailor the treatment plan to each individual patient's needs.
The researchers also developed a new way to handle the common problem of imbalanced survival data, where some patients live much longer than others. Their approach allows the model to learn from this uneven data and still make reliable predictions.
Overall, BioFusionNet represents an important step forward in using AI to improve breast cancer treatment and patient outcomes.
Technical Explanation
The researchers developed BioFusionNet, a deep learning framework that integrates image, genetic, and clinical data to achieve improved survival risk stratification for ER+ breast cancer patients.
To capture detailed image features, the model employs self-supervised feature extractors (DINO and MoCoV3) that are pretrained on histopathological image patches. These image features are then fused using a variational autoencoder and fed into a self-attention network to generate patient-level features.
The model uses a co-dual-cross-attention mechanism to combine the histopathological features with the genetic data, allowing it to capture the complex interplay between these modalities. Clinical data is incorporated using a feedforward network, further enhancing the predictive performance and achieving comprehensive multimodal feature integration.
To address the challenge of imbalanced survival data, the researchers introduced a weighted Cox loss function, which is specifically designed to handle this common issue in survival prediction tasks.
The BioFusionNet model achieved a mean concordance index of 0.77 and a time-dependent area under the curve of 0.84, outperforming state-of-the-art methods. It was able to predict risk (high versus low) with prognostic significance for overall survival in both univariate and multivariate analyses, demonstrating its potential to guide personalized treatment decisions and improve patient outcomes.
Critical Analysis
The paper provides a comprehensive and well-designed deep learning framework for survival risk stratification in ER+ breast cancer patients. The researchers' approach of integrating multi-modal data, including image, genetic, and clinical features, is a notable strength and aligns with the growing emphasis on comprehensive multimodal data integration in the field of cancer research.
However, the paper does not fully address potential limitations or areas for further research. For instance, the performance of the model on external validation datasets or in real-world clinical settings is not reported, which is an important consideration for assessing the generalizability and robustness of the approach.
Additionally, the paper could have delved deeper into the interpretability and explainability of the model's predictions, as this is a crucial aspect for clinical adoption and trust-building with healthcare professionals. Exploring the relative importance and interactions of the different data modalities would provide valuable insights into the model's decision-making process.
Further research could also investigate the potential to extend the BioFusionNet framework to other cancer types or explore the integration of additional data sources, such as radiomics or patient-reported outcomes, to enhance the predictive power and clinical utility of the model.
Conclusion
The BioFusionNet model developed by the researchers represents a significant advancement in the field of breast cancer survival prediction. By fusing image, genetic, and clinical data using a sophisticated deep learning architecture, the model achieves impressive performance in stratifying ER+ breast cancer patients into high and low-risk groups.
This research highlights the potential of comprehensive multimodal data integration and advanced AI techniques to improve personalized cancer care. The ability to accurately predict survival risk can empower clinicians to make more informed treatment decisions, leading to better outcomes for patients.
While further validation and refinement are needed, the BioFusionNet framework serves as a promising step towards the development of clinically-relevant AI tools that can transform the way breast cancer is managed and ultimately improve the lives of those affected by this devastating disease.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🔮
FORESEE: Multimodal and Multi-view Representation Learning for Robust Prediction of Cancer Survival
Liangrui Pan, Yijun Peng, Yan Li, Yiyi Liang, Liwen Xu, Qingchun Liang, Shaoliang Peng
0
0
Integrating the different data modalities of cancer patients can significantly improve the predictive performance of patient survival. However, most existing methods ignore the simultaneous utilization of rich semantic features at different scales in pathology images. When collecting multimodal data and extracting features, there is a likelihood of encountering intra-modality missing data, introducing noise into the multimodal data. To address these challenges, this paper proposes a new end-to-end framework, FORESEE, for robustly predicting patient survival by mining multimodal information. Specifically, the cross-fusion transformer effectively utilizes features at the cellular level, tissue level, and tumor heterogeneity level to correlate prognosis through a cross-scale feature cross-fusion method. This enhances the ability of pathological image feature representation. Secondly, the hybrid attention encoder (HAE) uses the denoising contextual attention module to obtain the contextual relationship features and local detail features of the molecular data. HAE's channel attention module obtains global features of molecular data. Furthermore, to address the issue of missing information within modalities, we propose an asymmetrically masked triplet masked autoencoder to reconstruct lost information within modalities. Extensive experiments demonstrate the superiority of our method over state-of-the-art methods on four benchmark datasets in both complete and missing settings.
5/14/2024
🤿
Comprehensive Multimodal Deep Learning Survival Prediction Enabled by a Transformer Architecture: A Multicenter Study in Glioblastoma
Ahmed Gomaa, Yixing Huang, Amr Hagag, Charlotte Schmitter, Daniel Hofler, Thomas Weissmann, Katharina Breininger, Manuel Schmidt, Jenny Stritzelberger, Daniel Delev, Roland Coras, Arnd Dorfler, Oliver Schnell, Benjamin Frey, Udo S. Gaipl, Sabine Semrau, Christoph Bert, Rainer Fietkau, Florian Putz
0
0
Background: This research aims to improve glioblastoma survival prediction by integrating MR images, clinical and molecular-pathologic data in a transformer-based deep learning model, addressing data heterogeneity and performance generalizability. Method: We propose and evaluate a transformer-based non-linear and non-proportional survival prediction model. The model employs self-supervised learning techniques to effectively encode the high-dimensional MRI input for integration with non-imaging data using cross-attention. To demonstrate model generalizability, the model is assessed with the time-dependent concordance index (Cdt) in two training setups using three independent public test sets: UPenn-GBM, UCSF-PDGM, and RHUH-GBM, each comprising 378, 366, and 36 cases, respectively. Results: The proposed transformer model achieved promising performance for imaging as well as non-imaging data, effectively integrating both modalities for enhanced performance (UPenn-GBM test-set, imaging Cdt 0.645, multimodal Cdt 0.707) while outperforming state-of-the-art late-fusion 3D-CNN-based models. Consistent performance was observed across the three independent multicenter test sets with Cdt values of 0.707 (UPenn-GBM, internal test set), 0.672 (UCSF-PDGM, first external test set) and 0.618 (RHUH-GBM, second external test set). The model achieved significant discrimination between patients with favorable and unfavorable survival for all three datasets (logrank p 1.9times{10}^{-8}, 9.7times{10}^{-3}, and 1.2times{10}^{-2}). Conclusions: The proposed transformer-based survival prediction model integrates complementary information from diverse input modalities, contributing to improved glioblastoma survival prediction compared to state-of-the-art methods. Consistent performance was observed across institutions supporting model generalizability.
5/22/2024
🔮
Advancing Head and Neck Cancer Survival Prediction via Multi-Label Learning and Deep Model Interpretation
Meixu Chen, Kai Wang, Jing Wang
0
0
A comprehensive and reliable survival prediction model is of great importance to assist in the personalized management of Head and Neck Cancer (HNC) patients treated with curative Radiation Therapy (RT). In this work, we propose IMLSP, an Interpretable Multi-Label multi-modal deep Survival Prediction framework for predicting multiple HNC survival outcomes simultaneously and provide time-event specific visual explanation of the deep prediction process. We adopt Multi-Task Logistic Regression (MTLR) layers to convert survival prediction from a regression problem to a multi-time point classification task, and to enable predicting of multiple relevant survival outcomes at the same time. We also present Grad-TEAM, a Gradient-weighted Time-Event Activation Mapping approach specifically developed for deep survival model visual explanation, to generate patient-specific time-to-event activation maps. We evaluate our method with the publicly available RADCURE HNC dataset, where it outperforms the corresponding single-modal models and single-label models on all survival outcomes. The generated activation maps show that the model focuses primarily on the tumor and nodal volumes when making the decision and the volume of interest varies for high- and low-risk patients. We demonstrate that the multi-label learning strategy can improve the learning efficiency and prognostic performance, while the interpretable survival prediction model is promising to help understand the decision-making process of AI and facilitate personalized treatment.
5/10/2024
🏷️
Biomarker based Cancer Classification using an Ensemble with Pre-trained Models
Chongmin Lee, Jihie Kim
0
0
Certain cancer types, namely pancreatic cancer is difficult to detect at an early stage; sparking the importance of discovering the causal relationship between biomarkers and cancer to identify cancer efficiently. By allowing for the detection and monitoring of specific biomarkers through a non-invasive method, liquid biopsies enhance the precision and efficacy of medical interventions, advocating the move towards personalized healthcare. Several machine learning algorithms such as Random Forest, SVM are utilized for classification, yet causing inefficiency due to the need for conducting hyperparameter tuning. We leverage a meta-trained Hyperfast model for classifying cancer, accomplishing the highest AUC of 0.9929 and simultaneously achieving robustness especially on highly imbalanced datasets compared to other ML algorithms in several binary classification tasks (e.g. breast invasive carcinoma; BRCA vs. non-BRCA). We also propose a novel ensemble model combining pre-trained Hyperfast model, XGBoost, and LightGBM for multi-class classification tasks, achieving an incremental increase in accuracy (0.9464) while merely using 500 PCA features; distinguishable from previous studies where they used more than 2,000 features for similar results.
6/17/2024